ZELGOR ABIRATERONE ACETATE TABLETS

Get a Price/Quote

ZELGOR ABIRATERONE ACETATE TABLETS Specification

Indication
Metastatic castration-resistant prostate cancer

Origin of Medicine
India

Pacakaging (Quantity Per Box)
120 Tablets per bottle

Dosage Form
Oral tablets

Salt Composition
Abiraterone Acetate

Drug Type
Allopathic

Ingredients
Abiraterone Acetate

Physical Form
Tablets

Function
Anti-cancer, Androgen biosynthesis inhibitor

Recommended For
Prostate Cancer Treatment

Dosage
As prescribed by physician

Dosage Guidelines
Take on an empty stomach, as directed

Suitable For
Adults

Quantity
120 Tablets

Storage Instructions
Store below 30C, protect from moisture

ZELGOR ABIRATERONE ACETATE TABLETS Trade Information

Packaging Details
PACK OF 120 TABLETS

Main Domestic Market
All India

About ZELGOR ABIRATERONE ACETATE TABLETS

Specifications:-

Brand Name : Zelgor
Contents: Abiraterone Acetate
Strength: 250 mg
Form: Tablets
Packing: Pack of 120 Tablets

Note :- Zelgor Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...........

Advanced Treatment for Prostate Cancer

Zelgor Abiraterone Acetate Tablets offer an advanced therapeutic approach for men diagnosed with metastatic castration-resistant prostate cancer. As an androgen biosynthesis inhibitor, Zelgor helps slow disease progression by significantly lowering testosterone levels. This prescription medication, developed in India by Sun Pharma, is administered orally and provides an important option for adults under the supervision of an oncologist.

Proper Usage and Administration

These oral tablets should be taken on an empty stomach, exactly as directed by your oncologist. Its crucial not to alter the dosage or schedule without consulting your physician. Adherence to proper timing enhances absorption and effectiveness. Patients should routinely monitor liver function and potassium levels during therapy, and pregnant women must avoid this medication due to contraindications.

Safe Handling and Storage

Store Zelgor tablets below 30C, away from moisture, to maintain their efficacy throughout their 24-month shelf life. Keep the medication in its original packaging out of reach of children. Patients should follow all storage instructions carefully and return unused or expired tablets to appropriate pharmaceutical collection services for safe disposal.

FAQs of ZELGOR ABIRATERONE ACETATE TABLETS:

Q: How should Zelgor Abiraterone Acetate Tablets be taken for optimal results?

A: Zelgor tablets must be taken orally on an empty stomach, precisely as prescribed by your oncologist. Do not eat for at least two hours before and one hour after taking the dose to ensure maximum absorption.

Q: What is Zelgor used for in prostate cancer management?

A: Zelgor is indicated for the treatment of metastatic castration-resistant prostate cancer. It functions as an androgen biosynthesis inhibitor, lowering testosterone levels to slow the growth and spread of prostate cancer cells.

Q: When should I avoid taking Zelgor Abiraterone Acetate Tablets?

A: You should not take Zelgor if you are pregnant, have hypersensitivity to Abiraterone, or as advised by your physician. This medication is strictly for adult male patients as prescribed by an oncologist.

Q: Where should Zelgor tablets be stored to maintain their effectiveness?

A: Store Zelgor tablets in a cool, dry place below 30C, protected from moisture, and keep them in their original packaging. Always keep the medication out of reach of children.

Q: What monitoring is needed during treatment with Zelgor?

A: Regular monitoring of liver function and potassium levels is necessary during treatment, as recommended by your healthcare provider. This helps manage potential side effects and ensures safety throughout the therapy.

Q: What are the benefits of using Zelgor for prostate cancer?

A: Zelgor helps in effectively reducing testosterone production, delaying disease progression, and improving outcomes in adult men with advanced metastatic castration-resistant prostate cancer, when used under strict medical supervision.

Tell us about your requirement